The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Reviews and OverviewsFull Access

Mortality in Offspring of Parents With Psychotic Disorders: A Critical Review and Meta-Analysis

Abstract

OBJECTIVE: Mortality risk in offspring of parents with psychotic disorders is a sensitive and important topic, but evidence on which to base plans for preventive services is limited. The authors synthesized evidence for mortality risk among offspring of parents with psychotic disorders and examined potential modifiers of risk such as offspring age and parental diagnosis. METHOD: Electronic reference and citation databases were searched. Secondary analyses were carried out to generate relative risk estimates and perform post hoc statistical power calculations. A meta-analysis of the association between maternal psychotic disorder and fetal death/stillbirth was conducted. RESULTS: Most of the relevant studies investigated the relationship between exposure to maternal schizophrenia and perinatal or infant mortality outcomes but were not truly population-based and lacked adequate power. Studies published since 1960 generally indicated higher than expected mortality risk in exposed offspring. Meta-analysis indicated an almost twofold higher risk of fetal death/stillbirth among offspring of women with psychoses. Notable gaps in the existing evidence include outcome beyond the first year of life, cause-specific mortality, and effects of exposure to specific parental conditions other than schizophrenia and of exposure to paternal versus maternal disorder. Etiological mechanisms are not fully understood. CONCLUSIONS: Large-scale population-based studies are needed to understand mortality risk in offspring of parents with psychoses. In the absence of etiological evidence, only general preventive measures can be taken. Prevention of offspring mortality at an early age is most likely to be achieved by identification and treatment of maternal disorder and greater provision of support to these vulnerable families.

Psychotic disorders affect childbearing in a number of ways, including lower rates of fertility in affected adults (13) and higher rates of obstetric complications in affected women (4, 5). Greater risk of fetal, perinatal, and infant mortality among exposed offspring has also been found, although there remains a need for the accurate and precise quantification of risk in the overall population of exposed offspring and in specific high-risk subgroups. In addition to estimation of relative risks for all-cause mortality, the elucidation of cause-specific risks and etiological mechanisms is also required to inform the development of preventive measures and interventions. For example, recent commentary highlighted the need for further research on possible links between parental mental disorder and sudden infant death syndrome (6). Our aim was to synthesize existing published evidence of associations between parental psychotic disorder and all-cause and cause-specific offspring mortality risk among all exposed offspring and according to possible modifiers of risk such as offspring age and sex, parental diagnosis, having the presence of psychotic disorder in both parents, separation from birth parent(s), and socioeconomic status.

Method

Search Strategy

Three electronic databases were searched (MEDLINE for data published from 1966 to the present, EMBASE from 1980, and PsycINFO from 1887) to identify relevant empirical quantitative studies. A broad range of subject headings was used to identify the relevant disorders and diagnoses. For each database search, three main search components (parental psychotic illness, offspring status, mortality) were created by combining subject headings with the “OR” operator, and the three components were then combined together by using the “AND” operator. Relevance was determined by screening titles and abstracts. Referencelists of relevant articles were screened for further potentially relevant studies, and citation searches were conducted by using the ISI Web of Science. The results are reported for the following exposure groups: 1) offspring of parents with schizophrenia and related disorders and 2) offspring of mothers with unspecified psychotic disorders.

Statistical Analyses

For studies where relative risk estimates were not presented, the reported data were used to calculate these estimates, together with their 95% confidence intervals (CIs). This step was not possible if numerators and denominators were not given in full. Relative risks and 95% CIs calculated by the lead author of this review are denoted as relative risk* and 95% CI*, respectively. Where numerators and denominators were fully reported, post hoc power calculations were performed to enable assessment of the degree of statistical power available to detect relative risks of two- to fourfold.

Meta-analyses were planned to examine mortality in the following offspring age categories: fetal, neonatal (birth to 28 completed days), postneonatal (29th day to end of first year), preschool age (1–4 years), school age (5–15 years), and young adults (16–30 years). However, because of the lack of relevant studies, the formal meta-analysis was performed only for the association between exposure to maternal psychotic disorder and fetal death/stillbirth. Psychotic disorder was defined broadly as schizophrenia and related disorders or any other psychotic disorder. Mantel-Haenszel pooled risk ratios were estimated, with a chi-square test for heterogeneity used to assess between-study differences in effect (7). Fixed-effects models were fitted if there was no evidence of heterogeneity (p<0.1), and risk ratios are presented as a forest plot (8). The forest plot shows study-specific risk ratios (and their 95% CIs) and the relative weighted contribution of each study, as well as the risk ratio estimate pooled across all studies. The analyses were performed with Stata statistical software (9).

Results

Summary of Relevant Studies

Sixteen relevant empirical quantitative studies of mortality in offspring of parents with psychotic disorders published between 1935 and 2004 were identified (1025), all but two (10, 11) of which were published since 1960. Most studies investigated the effect of parental schizophrenia per se (10, 11, 13–16) or the specific effect of maternal schizophrenia (12, 17–21). Jablensky et al. (19) also investigated maternal affective disorders (unipolar depression and bipolar disorder) as separate exposure categories. The other studies investigated the effects of unspecified postpartum psychosis (22, 23) and a range of maternal disorders, including psychotic illnesses (24, 25). Most studies investigated fetal, perinatal, or infant mortality outcomes, although some of the earlier studies included longer follow-up periods, such as 0 to 59 years (11), 0 to 15 years (13), and 0 to ≥50 years (14). Thus, there was a lack of recent evidence for mortality risk in exposed offspring beyond the first year of life. The quality of the evidence was varied, with the more recent population-based studies conducted with national registries being of the highest quality (1921). One original report was not translated into English (10), and one study (18) was excluded from the meta-analysis because of poor quality (specifically, small sample size and missing data). One study (24) was excluded from the critical review because of an insufficient number of mothers with psychotic disorders, and another (25) was excluded because results for psychotic disorders were not reported separately from results for nonpsychotic disorders. The 14 studies included in the critical review are summarized in Table 1.

Outcomes for Offspring of Parents With Schizophrenia and Related Disorders

The earliest studies were conducted in Germany (10, 11). The account of the first published study, by Essen-Moller, is available only in German (10), although Kallmann (11) briefly summarized Essen-Moller’s findings in English. In Essen-Moller’s study, probands were admitted with schizophrenia in Munich during 1904–1927, but the offspring sample size and follow-up period were not reported. No differences in mortality risk were found between exposed offspring overall and the general population, and there was no evidence for heterogeneity of effect by clinical form of schizophrenia, by maternal versus paternal disorder, or by timing of schizophrenia onset.

In Kallmann’s study (11), outcomes for offspring (N=2,120) of schizophrenic probands admitted in Berlin during 1892–1902 were investigated. His findings, similar to those of Essen-Moller, were that child mortality risk was independent of schizophrenia per se, of the specific form of the disease, and of the sex of the affected parent. However, the risks of mortality because of suicide and tuberculosis were higher than expected, with four- to fivefold higher proportional mortality rates for those causes. The proportion of all offspring who died by suicide was also reported (relative risk*=3.3, 95% CI* not estimable).

Rosenthal (26) postulated a “double dose” effect of inherited mortality risk in offspring of two schizophrenic parents. Testing this hypothesis in a secondary analysis of Kallmann’s data, he found no evidence of greater risk; 35% of these offspring (N=55) died before age 5 years, compared to 44.5% of the offspring with one affected parent. He also postulated that several gestational conditions could generate additional risk of poor outcome specific to maternal (versus paternal) schizophrenia. These conditions included medication toxicity, coma-inducing or convulsive therapy, inadequate diet, unusually high anxiety or excitatory states, and failure to exercise because of catatonia. He compared mortality to age 5 years in offspring of affected mothers (43.5%) versus fathers (39%) and again found insufficient evidence from Kallmann’s data to support this second hypothesis.

Sobel (12) examined data for offspring (N=222) of women with schizophrenia who delivered at New York State mental hospitals during 1950–1958. He reported a perinatal mortality rate of 8.1% (10 stillbirths, eight neonatal deaths), compared with 3.6% in the U.S. general population (relative risk*=2.3, 95% CI* not estimable); the rate of congenital malformations was 3.2% (seven cases), compared with approximately 1% in the national population (relative risk*=3.2, 95% CI* not estimable). Sobel argued that the incidence of “deviant fetal growth” and subsequent mortality risk could be higher among offspring of mothers with some subtypes of schizophrenia, thereby highlighting the need for using large data sets for investigation of these rare outcomes. Sobel’s study was the first published study to empirically indicate higher than expected risk of all-cause mortality among exposed offspring.

However, in accordance with the “physiological advantage hypothesis” of Huxley et al. (27), Erlenmeyer-Kimling (13) postulated that offspring of people with schizophrenia would have lower mortality risk. This hypothesis suggests the existence of genetic compensatory advantages that overcome selective disadvantages such as lower fertility and fecundity and render offspring of affected parents fitter than the general population. Examples of possible advantages given by Huxley et al. include “extreme resistance” to surgical or wound shock, burns, pain, arthritis, and many allergies and infections. To test the hypothesis, Erlenmeyer-Kimling calculated mortality rates in offspring (N=1,718) born during 1900–1959 to schizophrenic probands admitted to psychiatric hospitals in New York State and compared these rates with national population rates. The risk of infant mortality (i.e., deaths of live-born offspring during the first year of life) was lower among exposed offspring, a difference that was greater in girls (relative risk=0.4*, 95% CI* not estimable) than in boys (relative risk*=0.7). Relative risks were below 1.0 for both sexes in the 1–4-year age group, although this apparent protective effect was weak. For offspring ages 5–15 years, the relative risks were greater than 1.0 (relative risk*=1.3 in girls; relative risk*=1.2 in boys). When the data were pooled across all ages (0–15 years), there was no evidence of an effect for boys (relative risk*=1.0), but mortality risk was significantly lower among exposed girls (relative risk*=0.7). These results provided some support for the physiological advantage hypothesis, although no account was taken of possible environmental factors that could explain the lower risks found among exposed infants and young children. For example, institutionalization may have led to a lower prevalence of environmental hazards. Furthermore, no explanation for the heterogeneity of effect by offspring sex was offered.

Lindelius (14) investigated mortality in offspring (N=336) of schizophrenic probands admitted during 1900–1910 in a demographically stable area of rural Sweden, with 93% follow-up to 1960 achieved by using parish registers. Expected numbers of deaths per age-sex stratum were estimated in reference to national population rates and were compared with observed numbers. All-cause mortality was significantly lower than expected in exposed offspring to age 4 years, but, as the author suggested, this finding may have been a statistical artifact that occurred because the national reference rates included higher-risk urban populations. For all other age-sex strata, up to and through adulthood, all-cause mortality was slightly lower than expected in the exposed offspring. There was some indication of a higher mortality rate because of tuberculosis and a lower risk of suicide, although these cause-specific analyses lacked statistical power.

Using data from a large perinatal survey established in 1959 in Boston, Rieder et al. (15) investigated fetal and neonatal mortality in three parental diagnostic subgroups: 1) schizophrenia (N=93), 2) possible schizophrenia/schizophrenic spectrum (N=60), and 3) other disorders (neuroses, manic depression, “character disorder,” alcohol addiction with psychosis) (N=57). Comparison subjects without a psychiatric history were selected and matched with the psychiatric disorder subjects for ethnicity, socioeconomic status, maternal age, parity, and offspring multiplicity. There was some suggestion of a higher than expected risk for exposure group 1 only (relative risk*=2.0, 95% CI*=0.7–5.5), although the wide confidence interval indicates imprecision and nonsignificance.

Modrzewska (16) examined data for offspring of parents with schizophrenia (N=553) and comparison subjects with unaffected parents (N=624) in an isolated area of northern Sweden. All probands were born in the area during 1829–1960. Higher than expected risks of stillbirth (relative risk*=3.1, 95% CI*=1.3–7.2) and infant mortality (relative risk*=4.1, 95% CI*=1.8–9.5) were observed in exposed offspring. Low numbers precluded assessment of mortality risk in offspring with two affected parents (N=39), and cause of death could not be investigated because of poor documentation. Furthermore, a high prevalence of consanguineous marriage and intensive inbreeding affected the study’s external validity.

Wrede et al. (17) used a psychiatric register to investigate outcomes for offspring born to women with schizophrenia in Helsinki, Finland, during 1960–1964. Medical records were examined to assess diagnostic accuracy, and exposure status in terms of severity of maternal disorder was classified as “chronic” (permanent social deficit: N=54) or “mild” (1–3 admissions: N=117). Comparison subjects were randomly sampled from a population register (N=171). Nine perinatal deaths occurred, all but one among the mild exposure group (four stillbirths, four neonatal deaths) and the other among the comparison subjects (a stillbirth). The lack of deaths in the chronic exposure group was unexpected but could have occurred by chance or because of the high rate of loss to follow-up in that group. For all exposed offspring combined (N=171), the relative risks of stillbirth (relative risk*=4.0, 95% CI*=0.5–35.4) and perinatal mortality (relative risk*=8.0, 95% CI*=1.0–63.3) were higher than expected, but the confidence intervals for these estimates are very wide and imprecise.

Miller and Finnerty (18) recruited women meeting the Research Diagnostic Criteria for schizophrenia or schizoaffective disorder (N=44) in Chicago during 1993–1995 and a comparison group (N=50) of women without major mental illness who were matched with the schizophrenic subjects for age, ethnicity, and socioeconomic status. Subjects were questioned about their sexuality, pregnancies, and child rearing, but there were missing data concerning history of stillbirth (data on history of stillbirth were available for 36 affected women and 46 comparison subjects). Comparable stillbirth rates were reported in the two groups (two cases in the affected group, three in the comparison group), but this evidence is weak because of the small sample sizes and because the baseline risk of stillbirth reported in the comparison group (65 per 1,000) was approximately nine times higher than the contemporary national rate (28).

Jablensky et al. (19, 29) linked population and psychiatric registers to investigate mortality among all births occurring in Western Australia during 1980–1992 to mothers with schizophrenia (N=618), bipolar disorder (N=1,301), and unipolar depression (N=1,255). Comparison offspring (N=3,129) of mothers without a psychiatric history were randomly selected from the general population. There was no evidence of higher than expected perinatal or infant mortality among offspring exposed to maternal schizophrenia (stillbirth: odds ratio=0.8, 95% CI=0.3–2.3; neonatal death: odds ratio=1.0, 95% CI=0.3–3.0; postneonatal death: odds ratio=1.1, 95% CI=0.2–5.1). There was a suggestion that these offspring were at increased risk during early childhood (odds ratio=2.2, 95% CI=0.7–7.3), although this estimate lacked statistical significance and precision. No evidence was found for higher risk of mortality at any age among offspring exposed to maternal bipolar disorder (stillbirth: odds ratio=0.9, 95% CI=0.4–1.9; neonatal death: odds ratio=0.8, 95% CI=0.3–2.0; postneonatal death: odds ratio=1.2, 95% CI=0.5–3.0; early childhood death: odds ratio=1.3, 95% CI=0.4–4.6). However, as Table 2 shows, these data lacked power for examining offspring mortality in relation to specific maternal disorders, as the primary aim of the study was to investigate more commonly occurring outcomes during pregnancy, delivery, and the neonatal period.

Two large Scandinavian registry-based studies (20, 21) have provided the best available evidence to date. Bennedsen et al. (20) investigated all single births (N=2,230) to mothers admitted with schizophrenia to public psychiatric facilities in Denmark during 1969–1993; the comparison group consisted of subjects randomly sampled from the general population (N=123,544). As there were no private psychiatric inpatient facilities in Denmark, this investigation was truly a population-based study. Relative risks were adjusted for year of birth, offspring sex, maternal age, and parity, although no adjustment was made for socioeconomic status, smoking status, substance abuse, and psychoactive treatment. Higher than expected relative risks in exposed offspring were observed for stillbirth (relative risk=1.6, 95% CI=1.0–2.6; adjusted relative risk=1.5, 95% CI=0.9–2.4), neonatal death (relative risk=1.4, 95% CI=0.9–2.3; adjusted relative risk=1.3, 95% CI=0.8–2.1), and congenital malformation (relative risk=1.8, 95% CI=1.1–2.9; adjusted relative risk=1.7, 95% CI=1.0–2.8), with larger effects observed for postneonatal death (relative risk=2.8, 95% CI=1.7–4.5; adjusted relative risk=2.8, 95% CI=1.7–4.6) and sudden infant death syndrome (relative risk=4.7, 95% CI=2.6–8.8; adjusted relative risk=5.2, 95% CI=2.8–9.7). However, offspring were classified as being “exposed” even if the first maternal admission for schizophrenia occurred after the offspring death, an event that could be a contributory factor in maternal disease onset, thereby introducing a potential reverse causation bias (30).

Nilsson et al. (21) conducted a similar investigation of all single births during 1983–1997 to mothers admitted with schizophrenia in Sweden during 1977–1997. Comparison subjects were offspring of unaffected mothers in the general population (N=1.56 million). Potential problems of reverse causality were addressed by estimating relative risks for three exposed subgroups: 1) offspring of mothers who first received the diagnosis at any time during the study period (N=2,096), 2) offspring of mothers who first received the diagnosis before birth of the offspring (N=935), and 3) offspring of mothers who first received the diagnosis during pregnancy (N=201), with groups 2 and 3 providing the more stringent definitions of exposure. Odds ratios were estimated with adjustment for maternal age, smoking, education, country of birth, marital status, and the presence of pregnancy-induced hypertension. Offspring whose mothers received the diagnosis of schizophrenia before the offspring’s birth were found to be at higher than expected risk for stillbirth (odds ratio=2.5, 95% CI=1.3–5.1; adjusted odds ratio=1.7, 95% CI=0.9–3.5), and they also had a higher—although nonsignificantly higher—risk for infant death (odds ratio=1.8, 95% CI=0.9–3.6; adjusted odds ratio=1.4, 95% CI=0.7–2.8). There was some indication of even greater risk if the mother’s first admission occurred during pregnancy (stillbirth: odds ratio=4.4, 95% CI=1.4–13.8; adjusted odds ratio=2.5, 95% CI=0.8–7.9) (infant death: odds ratio=3.1, 95% CI=1.0–9.8; adjusted odds ratio=2.1, 95% CI=0.7–6.6), although these subgroup analyses lack statistical precision.

Outcomes for Offspring of Mothers With Unspecified Psychotic Disorders

Paffenbarger et al. (22) used inpatient records to identify women ages 15–44 years (N=126) with first-onset psychotic episodes during pregnancy (or in the 6 months prior to pregnancy) in 1940–1958 in Cincinnati. Obstetric data were obtained, and comparison subjects (N=252), matched for maternity unit and ethnicity, were also selected. There were 10 deaths among exposed offspring (seven fetal deaths and three neonatal deaths) and six among the comparison subjects (four fetal deaths and two neonatal deaths). The fetal and neonatal death rates, adjusted for maternal age and parity, were twice as high in exposed offspring than in the comparison offspring (7% versus 3%) (p=0.02).

Howard et al. (23) conducted a population-based retrospective cohort study in England using the General Practice Research Database. Outcomes in offspring born during 1996–1998 to women with a diagnosis of a psychotic disorder (N=199) were compared to those of offspring born to comparison subjects (N=787) matched for maternal age and general practice. Five stillbirths occurred in both groups—a significantly greater proportion among the exposed group (2.5% versus 0.6%) (odds ratio=4.0, 95% CI=1.1–4.3). Four neonatal deaths and one postneonatal death also occurred among exposed offspring, compared with none among the live-born comparison subjects.

Two other studies were conducted to investigate the effects of a broad range of maternal psychiatric illnesses, including psychotic disorders. Zax et al. (24) analyzed data for offspring of women with schizophrenia (N=29), neurotic depression (N=56), and personality disorder (N=42) in Rochester, N.Y., from 1959 onward. Bagedahl-Strindlund et al. (25) investigated outcome for offspring born to women (N=177) with a diagnosis of unspecified functional psychoses (19%), schizophrenia and schizoaffective disorder (16%), affective disorder (28%), neuroses (23%), and alcohol/drug addiction (14%) in Stockholm County, Sweden, during 1976–1977. In both investigations, mothers with psychotic illnesses constituted a minority of the sample. The study by Zax et al. included too few women with psychotic disorders, and Bagedahl-Strindlund et al. did not report results separately for women with psychotic versus nonpsychotic disorders. For these reasons, the results of these two studies were excluded from the review.

Meta-Analysis

A meta-analysis of the relationship between maternal psychotic disorder and fetal death/stillbirth was performed, as there were a sufficient number of relevant studies that met the criteria for meta-analysis (N=6) (17, 19–23). Studies were excluded from the meta-analysis for the following reasons: 1) stillbirth rates were not reported (10, 11, 13, 14), 2) results were not reported separately for psychotic versus nonpsychotic disorders (24, 25), 3) paternal disorder was also included in the “exposed” offspring category (15, 16), or 4) numerators or denominators for the reference population were not reported (12). Another study (18) was excluded because of poor quality. All six studies included in the meta-analysis were published since 1960, and all but one (22) were published from the mid-1980s onward, which probably reflects the evolution of accepted methods of scientific reporting.

The results are presented in Figure 1. The pooled estimate indicated a doubling of mortality risk in exposed offspring (Mantel-Haenszel pooled relative risk*=1.9, 95% CI*=1.4–2.6). In all but one study—Jablensky et al. (19)—the relative risk was above 1.0, and there was no evidence of between-study heterogeneity (χ2=6.35, df=5, p=0.27). Exclusion of studies is unlikely to have materially altered the results, as almost all studies published since 1960 indicated a higher than expected risk of fetal death/stillbirth.

Discussion

Summary of Main Findings

On the basis of informal interpretation and formal meta-analysis, the evidence published since 1960 generally indicated that exposure to maternal psychotic illness is associated with a higher than expected risk of perinatal and infant mortality. Meta-analysis indicated an almost twofold relative risk for fetal death/stillbirth among offspring of affected mothers, which is comparable in magnitude to that observed for maternal smoking during pregnancy (31). Between 1968 and 1980, four studies were published that included offspring exposed to paternal schizophrenia (1316). In each of these studies, the relative risk for exposure to parental versus maternal disorder was not estimable because the data were not reported separately, and statistical power for making such a comparison was in any case lacking. Our findings indicate a need for evidence concerning the effects of exposure to paternal disorder. Other important gaps in the evidence base are highlighted and discussed in the later section on “Lessons for Future Research.”

Putative Causal Mechanisms

Existing evidence suggests that causal mechanisms vary according to offspring age. Thus a combination of genetic, antenatal, and obstetric factors may explain the higher risks of fetal, perinatal, and neonatal death in exposed offspring; for example, an as yet unspecified common genetic or environmental mechanism linking schizophrenia and congenital malformation has been suggested (20). Women with schizophrenia are more likely to continue smoking or misusing substances during pregnancy and to have unrecognized comorbid medical conditions (32). Women with schizophrenia and other mental disorders also tend to have lower attendance at or poorer quality antenatal care visits (3336). These factors, together with low socioeconomic status (37), may explain the higher likelihood of restricted fetal growth and preterm birth observed in offspring of women with schizophrenia, which in turn strongly predicts increased risk of perinatal and infant mortality (38).

Psychotropic medication toxicity may also cause congenital malformation and fetal, perinatal, and neonatal death, but existing evidence in this area is inconclusive (37, 39). It could be that these potentially adverse effects are a recent phenomenon, as most early studies failed to show a higher risk of mortality (10, 11, 13, 14), and dopamine-receptor-blocking drug treatment for schizophrenia was not introduced until the 1950s. Indeed Sobel’s 1961 study (12) was the first to indicate higher mortality risks. Evidence for a greater incidence of obstetric complications is also equivocal (37). Using Danish national registers, Bennedsen et al. (36) found that offspring of mothers with schizophrenia tended to have lower Apgar scores, but there was no evidence of a greater incidence for specific complications. In an Australian register-based study, Jablensky et al. (19) reported higher rates of pregnancy, obstetric, and neonatal complications, such as placental abnormality, antepartum hemorrhage, and fetal distress, in women with schizophrenia and affective disorder. Two meta-analyses have also indicated higher risk of complication during pregnancy and birth in women with schizophrenia (4, 5).

During infancy and childhood, offspring of mentally ill people may be more likely to experience neglect and adverse domestic environments (25, 40). Brown and Davidson (41) investigated accident rates in children (N=420) ages <16 years in inner London and found a strong interaction between social class and maternal psychiatric disorder (p<0.001). The highest accident rate was observed among offspring of affected working-class mothers (19.2 per 100 children per year), followed by offspring of unaffected working-class mothers (9.6 per 100), offspring of affected middle-class mothers (5.3 per 100), and offspring of unaffected middle-class mothers (1.5 per 100).

Salmon et al. (42) investigated the prevalence of parenting problems after joint mother-infant psychiatric admissions in England. Nine percent of all women admitted (N=1,081) and 21% of those with schizophrenia (N=223) were perceived by staff to be at significant risk of harming their infants on discharge, although the study used a broad definition of harm that included emotional abuse and neglect. Using the same data, Howard et al. (43) found that 23% of all women admitted and 48% of those with schizophrenia were discharged under formal social service supervision. Investigation of a large community-based sample of more than 8,000 adults in Ontario, Canada, suggested two- to threefold higher rates of self-reported childhood physical or sexual abuse in offspring of mentally ill people, with especially high risk if either parent had an antisocial disorder (44). However, this evidence is weakened because of a high likelihood of biased recall among adult subjects, which may result in information bias in estimating prevalence of abuse during childhood. Furthermore, severity of abuse and subsequent mortality risk were not explored.

No population-based studies of offspring homicide by parents with psychotic illness were identified in the review. Bennedsen et al. (20) reported a high relative risk for sudden infant death syndrome in the offspring of schizophrenic mothers, which, as the authors pointed out, could include an unknown number of disguised homicides. The possibility of homicide in sudden infant death syndrome is controversial, and estimating the frequency of such events at the population level has to date proved impossible. Also the extreme rarity of these events would suggest that, even if relative risks for this outcome were higher, the phenomenon would explain little of the overall excess mortality risk.

When offspring reach adolescence, higher rates of mental disorder and substance misuse, as well as risk-taking, violent, or suicidal behavior, may place exposed offspring at higher mortality risk. For example, Chang et al. (45) found mental disorder in more than one-half of their sample (ages 6–18 years) of offspring of people with bipolar disorder, and Brent et al. (46) estimated a sixfold higher risk of suicide attempt in the offspring of index attempters. Our review found no population-based studies of mortality during adolescence and early adulthood in offspring of affected parents.

Lessons for Future Research

This review highlighted important gaps in the following areas of the current evidence base:

The effect of exposure to paternal versus maternal disorder and of exposure to two affected parents versus one affected parent

The modifying effects of offspring sex and age, specifically risk of mortality beyond the first year of life

Cause-specific mortality and etiological mechanisms and pathways

The effect of exposure to disorders other than maternal schizophrenia (e.g., bipolar disorder, dual diagnosis)

The confounding and modifying effects of factors such as socioeconomic status and separation from birth parent(s)

Two of these points are particularly noteworthy. First, our review identified only one study (19) that specifically investigated mortality risk associated with maternal bipolar disorder, and, as reported in the Results section, there was no evidence of higher risk of mortality in these offspring. In earlier studies these mothers are likely to have been misclassified as having other diagnoses, but to an unknown degree. Benazzi and Akiskal (47) found that about one-half of patients with major depressive episodes have type II bipolar disorder, and Thomas (48) reported that the disorder is often misdiagnosed as schizophrenia in the postpartum period because of the presence of “extreme psychotic and mixed features.” Thus, the prevalence of bipolarity may be higher than previously thought (48), and even high-quality registry-based studies tend to exclude patients with less severe forms of the disorder (49). Investigation of the effects of maternal bipolar disorder in an evolving diagnostic framework is a challenge for future research. Second, in all studies reviewed there were no data regarding the frequency or effect of temporary or permanent removal of offspring from their birth parent(s). The prevalence of parent-offspring separation is known to be high in this group (43), and separation could be an important modifier of risk. These infants and children may be at higher risk because of the introduction of an inferior substitute child-rearing environment, or conversely, they could be at lower risk because of the removal of exposure to neglect and other hazards that are directly related to the parental psychotic disorder. Parent-offspring separation could also be an important source of bias, as these offspring may be more likely to be lost to follow-up. Family setting (i.e., whether the infant is raised in a two-parent family, by a single mother, or in some other type of setting) could also be an important modifier of risk. These factors have not been investigated to date, as the relevant variables do not currently exist in national registers.

Future investigators should also be aware that most of the studies identified in this review had two fundamental methodological flaws: 1) they were not truly population based and 2) they lacked sufficiently large sample sizes to detect main effects with precision and had only minimal statistical power for detecting interactions and conducting subgroup analyses.

Table 2 presents post hoc statistical power calculations. The relevant information was not available for three studies (10, 11, 14). These calculations indicate that, with the exception of four studies (12, 13, 20, 21), investigations published to date have lacked adequate power to detect a twofold relative risk for all-cause mortality as a main effect. Even the large registry-based studies were underpowered to investigate effects in subgroups such as offspring exposed to onset of maternal schizophrenia during pregnancy (21).

Sample sizes have been inadequate because of the rarity of mortality at a young age and because of logistical problems in recruiting and prospectively following up large population-based samples. Because of the general downward trend in perinatal, infant, and childhood mortality rates over the last four decades, even larger sample sizes are now required. Also, some studies have primarily assessed more commonly occurring outcomes, such as disease inheritance (e.g., Modrzewska [16]), pregnancy and obstetric complications (e.g., Jablensky et al. [19]), or health care utilization (e.g., Howard et al. [23]), with mortality outcomes reported as secondary findings. This review strongly indicates a need for the use of comprehensive computerized national registers to investigate offspring mortality at the whole-population level. To detect main and subgroup effects with precision, sample sizes of several thousand offspring within each exposure group of interest are required.

Two register-based Scandinavian studies (20, 21) that were set up specifically to investigate offspring mortality outcomes have provided the best evidence to date. Record linkage between general population and psychiatric admission registers offers the potential for conducting truly population-based longitudinal studies (5052). These registers are ideal for investigation of this topic, for the following reasons:

1.

Statistical modeling of rare events, such as cause-specific mortality in children and young adults, is possible. The registers provide sufficient statistical power to investigate subgroup effects as well as main effects with precision.

2.

The biases that are common to many epidemiological surveys are minimal. For example, information bias is low, as data for explanatory and outcome variables are collected prospectively so that equivalent information is obtained irrespective of subsequent outcome status. Loss to follow-up occurs only through migration from the country. Analysis of cause-specific mortality can take into account competing risks, because deaths due to other causes are recorded.

3.

High levels of ascertainment for both explanatory and outcome variables are achieved through mandatory participation. Data validity and accuracy are also generally high, and record linkage is achieved with almost total completeness by using a unique personal identifier.

4.

A whole population cohort can be studied retrospectively over several decades.

Implications for Service Development

High-quality evidence is required to inform risk management strategies across the various agencies that assess needs and provide care, such as mental health, primary care, maternal and child health, and social service agencies. The future development of these services is dependent on successful identification and elucidation of causal mechanisms that are specific to parental diagnoses and offspring age. In the absence of this evidence, preventive strategies should focus on achieving 1) improved standards of maternity care, including screening and early treatment of psychotic disorder during antenatal and postnatal periods; 2) enhanced multiagency support for affected families with infants and young children; and 3) better parenting skills for people with psychotic illnesses.

TABLE 1
TABLE 2

Received March 26, 2004; revision received Sept. 22, 2004; accepted Oct. 26, 2004. From the Centre for Women’s Mental Health Research, School of Psychiatry and Behavioural Sciences, University of Manchester; and the Biostatistics Group, School of Epidemiology and Health Sciences, University of Manchester. Address correspondence and reprint requests to Dr. Webb, Centre for Women’s Mental Health Research, University of Manchester, Williamson Bldg., Oxford Rd., Manchester M13 9PL, U.K.; (e-mail).

Figure 1.

Figure 1. Meta-Analysis of Exposure to Maternal Psychotic Disorder and Fetal Death/Stillbirth Ratea

aTest for heterogeneity: χ2=6.35, df=5, p=0.27 (the nonsignificant p value indicates no evidence for variation in the study-specific risk ratios. The fixed-effects model presented here thus provides a reasonable summary of the results from the studies in the meta-analysis).

References

1. Nimgaonkar VL: Reduced fertility in schizophrenia: here to stay? Acta Psychiatr Scand 1998; 98:348–353Crossref, MedlineGoogle Scholar

2. Baron M, Risch N, Mendlewicz J: Differential fertility in bipolar affective illness. J Affect Disord 1982; 4:103–112Crossref, MedlineGoogle Scholar

3. Raoof NT, Pearson RM, Turner P: Lithium inhibits human sperm in vitro. Br J Clin Pharmacol 1989; 28:715–717Crossref, MedlineGoogle Scholar

4. Sacker A, Done DJ, Crow TJ: Obstetric complications in children born to parents with schizophrenia: a meta-analysis of case-control studies. Psychol Med 1996; 26:279–287Crossref, MedlineGoogle Scholar

5. Cannon M, Jones PB, Murray RM: Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry 2002; 159:1080–1092LinkGoogle Scholar

6. Howard L, Hannam S: Sudden infant death syndrome and psychiatric disorders. Br J Psychiatry 2003; 182:379–380Crossref, MedlineGoogle Scholar

7. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959; 22:719–748MedlineGoogle Scholar

8. Egger M, Smith GD, Phillips AN: Meta-analyses: principles and procedures. BMJ 1997; 315:1533–1537Crossref, MedlineGoogle Scholar

9. Stata Reference Manual: Release 8.0. College Station, Tex, Stata Corp, 2003Google Scholar

10. Essen-Moller E: Untersuchungen uber die Fruchtbarkeitgewisser Gruppen von Geisteskranken. Acta Psychiatr Neurol Suppl 1935; 8:1–314Google Scholar

11. Kallmann FJ: The Genetics of Schizophrenia. New York, JJ Augustin, 1938Google Scholar

12. Sobel DE: Infant mortality and malformations in children of schizophrenic women: preliminary data and suggested research. Psychiatr Q 1961; 35:60–64CrossrefGoogle Scholar

13. Erlenmeyer-Kimling L: Mortality rates in the offspring of schizophrenic parents and a physiological advantage hypothesis. Nature 1968; 220:798–800Crossref, MedlineGoogle Scholar

14. Lindelius R: A study of schizophrenia: a clinical, prognostic and family investigation. Acta Psychiatr Scand Suppl 1970; 216:1–125MedlineGoogle Scholar

15. Rieder RO, Rosenthal D, Wender P, Blumenthal H: The offspring of schizophrenics. Arch Gen Psychiatry 1975:32; 200–211Google Scholar

16. Modrzewska K: The offspring of schizophrenic parents in a North Swedish isolate. Clin Genet 1980; 17:191–201Crossref, MedlineGoogle Scholar

17. Wrede G, Mednick SA, Huttunen MO, Nilsson CG: Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers, II, in Children at Risk From Schizophrenia: Longitudinal Perspective. Edited by Watt NF, Anthony EJ, Wynne LC, Rolfe JE. Cambridge, UK, Cambridge University Press, 1984, pp 515–525Google Scholar

18. Miller LJ, Finnerty M: Sexuality, pregnancy, and childbearing among women with schizophrenia-spectrum disorders. Psychiatr Serv 1996; 47:502–506LinkGoogle Scholar

19. Jablensky AV, Morgan V, Zubrick SR, Bower C, Yellachich L-A: Pregnancy, delivery, and neonatal complications in a population cohort of women with schizophrenia and major affective disorders. Am J Psychiatry 2005; 162:79–91LinkGoogle Scholar

20. Bennedsen BE, Mortensen PB, Olesen, AV, Henriksen TB: Congenital malformations, stillbirths, and infant deaths among children of women with schizophrenia. Arch Gen Psychiatry 2001; 58:674–679Crossref, MedlineGoogle Scholar

21. Nilsson E, Lichtenstein P, Cnattingius S, Murray RM, Hultman CM: Women with schizophrenia: pregnancy outcome and infant death among their offspring. Schizophr Res 2002; 58:221–229Crossref, MedlineGoogle Scholar

22. Paffenbarger RS, Steinmetz CH, Pooler BG, Hyde RT: The picture puzzle of the postpartum psychosis. J Chronic Dis 1961; 13:161–173Crossref, MedlineGoogle Scholar

23. Howard LM, Goss C, Leese M, Thornicroft G: Medical outcome of pregnancy in women with psychotic disorders and their infants in the first year after birth. Br J Psychiatry 2003; 182:63–67Crossref, MedlineGoogle Scholar

24. Zax M, Sameroff AJ, Babigian HM: Birth outcomes in the offspring of mentally disordered women. Am J Orthopsychiatry 1977; 47:218–230Crossref, MedlineGoogle Scholar

25. Bagedahl-Strindlund M, Tunell R, Nilsson B: Children of mentally ill mothers: mortality and utilization of paediatric health services. Acta Paediatr Scand 1988; 77:242–250Crossref, MedlineGoogle Scholar

26. Rosenthal D: The offspring of schizophrenic couples. J Psychiatr Res 1966; 4:169–188Crossref, MedlineGoogle Scholar

27. Huxley J, Mayr E, Osmond H, Hoffer A: Schizophrenia as a genetic morphism. Nature 1964; 204:220–221Crossref, MedlineGoogle Scholar

28. Arias E, Anderson RN, Kung HC, Murphy SL, Kochanek KD: Deaths: Final Data for 2001: National Vital Statistics Reports, vol 52, number 3. Hyattsville, Md, National Center for Health Statistics, 2003Google Scholar

29. Jablensky A, Zubrick S, Morgan V, Bower C, Pinder T: The offspring of women with schizophrenia and affective psychoses: a population study (abstract). Schizophr Res 2000; 41(special issue):8Google Scholar

30. Marquis GS, Habicht JP, Lanata CF, Black RE, Rasmussen KM: Association of breastfeeding and stunting in Peruvian toddlers: an example of reverse causality. Int J Epidemiol 1997; 26:349–356Crossref, MedlineGoogle Scholar

31. Wisborg K, Kesmodel U, Henriksen TB, Olsen SF, Secher NJ: Exposure to tobacco smoke in utero and the risk of stillbirth and death in the first year of life. Am J Epidemiol 2001; 154:322–327Crossref, MedlineGoogle Scholar

32. Jeste DV, Gladsjo JA, Lindamer LA, Lacro JP: Medical comorbidity in schizophrenia. Schizophr Bull 1996; 22:413–430Crossref, MedlineGoogle Scholar

33. Wrede G, Mednick SA, Huttenen MO, Nilsson CG: Pregnancy and delivery complications in the births of an unselected series of Finnish children with schizophrenic mothers. Acta Psychiatr Scand 1980; 62:369–381Crossref, MedlineGoogle Scholar

34. Bagedahl-Strindlund M: Mentally ill mothers and their children: an epidemiological study of antenatal care consumption, obstetric conditions, and neonatal health. Acta Psychiatr Scand 1986; 74:32–40Crossref, MedlineGoogle Scholar

35. Kelly RH, Danielson BH, Golding JM, Anders TF, Gilbert WM, Zatzick DF: Adequacy of prenatal care among women with psychiatric diagnoses giving birth in California in 1994 and 1995. Psychiatr Serv 1999; 50:1584–1590LinkGoogle Scholar

36. Bennedsen BE, Mortensen PB, Olesen AV, Henrikson TB, Frydenberg M: Obstetric complications in women with schizophrenia. Schizophr Res 2001; 47:167–175Crossref, MedlineGoogle Scholar

37. Bennedsen B: Adverse pregnancy outcome in schizophrenic women: occurrence and risk factors. Schizophr Res 1998; 33:1–26Crossref, MedlineGoogle Scholar

38. Bennedsen BE, Mortensen PB, Olesen AV, Henriksen TB: Preterm birth and intra-uterine growth retardation among children of women with schizophrenia. Br J Psychiatry 1999; 175:239–245Crossref, MedlineGoogle Scholar

39. Webb RT, Howard L, Abel KM: Antipsychotic drugs for non-affective psychosis during pregnancy and postpartum. Cochrane Database Syst Rev 2004; (2):CD004411Google Scholar

40. Leverton TJ: Parental psychiatric illness: the implications for children. Curr Opin Psychiatry 2003; 16:395–402Google Scholar

41. Brown GW, Davidson S: Social class, psychiatric disorder of mother, and accidents to children. Lancet 1978; 1:378–381Crossref, MedlineGoogle Scholar

42. Salmon M, Abel K, Cordingley L, Friedman T, Appleby L: Clinical and parenting skills outcomes following joint mother-baby psychiatric admission. Aust N Z J Psychiatry 2003; 37:556–562Crossref, MedlineGoogle Scholar

43. Howard L, Shah N, Salmon M, Appleby L: Predictors of social services supervision of babies of mothers with mental illness after admission to a psychiatric mother and baby unit. Soc Psychiatry Psychiatr Epidemiol 2003; 38:450–455Crossref, MedlineGoogle Scholar

44. Walsh C, MacMillan H, Jamieson E: The relationship between parental psychiatric disorder and child physical and sexual abuse: findings from the Ontario Health Supplement. Child Abuse Negl 2002; 26:11–22Crossref, MedlineGoogle Scholar

45. Chang KD, Steiner H, Ketter A: Psychiatric phenomenology of child and adolescent bipolar offspring. J Am Acad Child Adolesc Psychiatry 2000; 39:453–460Crossref, MedlineGoogle Scholar

46. Brent DA, Oquendo M, Birmaher B, Greenhill L, Kolko D, Stanley B, Zelazny J, Brodsky B, Bridge J, Ellis S, Salazar JO, Mann JJ: Familial pathways to early-onset suicide attempt: risk for suicidal behavior in offspring of mood-disordered suicide attempters. Arch Gen Psychiatry 2002; 59:801–807Crossref, MedlineGoogle Scholar

47. Benazzi F, Akiskal HS: Refining the evaluation of bipolar II: beyond the strict SCID-CV guidelines for hypomania. J Affect Disord 2003; 73:33–38Crossref, MedlineGoogle Scholar

48. Thomas P: The many forms of bipolar disorder: a modern look at an old illness. J Affect Disord 2004; 79(suppl 1):S3-S8Google Scholar

49. Klanning U, Laursen TM, Licht RW, Kyvik KO, Skytthe A, Mortensen PB: Is the risk of bipolar disorder in twins equal to the risk in singletons? a nationwide register-based study. J Affect Disord 2004; 81:141–145Crossref, MedlineGoogle Scholar

50. Munk-Jørgensen P, Kastrup M, Mortensen PB: The Danish psychiatric register as a tool in epidemiology. Acta Psychiatr Scand Suppl 1993; 370:27–32Crossref, MedlineGoogle Scholar

51. Mortensen PB: The untapped potential of case registers and record linkage in psychiatric epidemiology. Epidemiol Rev 1995; 17:205–209Crossref, MedlineGoogle Scholar

52. Munk-Jørgensen P, Mortensen PB: The Danish psychiatric central register. Dan Med Bull 1997; 44:82–84MedlineGoogle Scholar